West Pharmaceutical Services, Inc.WSTNYSE
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank31
3Y CAGR-69.9%
5Y CAGR-56.9%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-69.9%/yr
Quarterly compound
5Y CAGR
-56.9%/yr
Recent deceleration
Percentile
P31
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.09% |
| Q3 2025 | 4.97% |
| Q2 2025 | 9.74% |
| Q1 2025 | -6.72% |
| Q4 2024 | 0.21% |
| Q3 2024 | 6.40% |
| Q2 2024 | 0.96% |
| Q1 2024 | -5.03% |
| Q4 2023 | -2.06% |
| Q3 2023 | -0.89% |
| Q2 2023 | 5.35% |
| Q1 2023 | 1.06% |
| Q4 2022 | 3.21% |
| Q3 2022 | -11.04% |
| Q2 2022 | 7.21% |
| Q1 2022 | -1.28% |
| Q4 2021 | 3.17% |
| Q3 2021 | -2.42% |
| Q2 2021 | 7.91% |
| Q1 2021 | 15.63% |
| Q4 2020 | 5.84% |
| Q3 2020 | 4.06% |
| Q2 2020 | 7.25% |
| Q1 2020 | 3.41% |
| Q4 2019 | 4.23% |
| Q3 2019 | -2.90% |
| Q2 2019 | 5.89% |
| Q1 2019 | 4.97% |
| Q4 2018 | -2.18% |
| Q3 2018 | -3.60% |
| Q2 2018 | 7.59% |
| Q1 2018 | 0.05% |
| Q4 2017 | 4.37% |
| Q3 2017 | 0.20% |
| Q2 2017 | 2.58% |
| Q1 2017 | 1.47% |
| Q4 2016 | 1.46% |
| Q3 2016 | -2.91% |
| Q2 2016 | 7.15% |
| Q1 2016 | 0.67% |